Ajanta Pharma Releases FY'26 Sustainability Report Highlighting Decarbonisation and Capacity Expansion
Ajanta Pharma Ltd · Others (Uncategorized) · 30 Sept 2026, 2:57 pm
Ajanta Pharma Releases FY'26 Sustainability Report Highlighting Decarbonisation and Capacity Expansion Ajanta Pharma submitted its voluntary FY'26 Sustainability Report, aligned with GRI Standards. Operational highlights include revenue rising 17% YoY to ₹5,453 cr., supported by tripling liquid formulation capacity at Pithampur to 18mn bottles annually. On ESG metrics, Scope 1 emissions fell 47% to 3,364 tCO2e, while installed solar capacity reached 16.6 MW, meeting 34% of energy needs. R&D investments reached ₹252 cr. (4.6% of revenue), delivering 53 product launches globally. Zero fatalities, zero product recalls, and zero data breaches were reported during the fiscal.
Original exchange filing (PDF)
More announcements from Ajanta Pharma Ltd
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 18, 2026 for Aayush Agrawal, .... · 18 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 16, 2026 for Aayush Agrawal, .... · 17 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2026 for Aayush Agrawal, .... · 09 Nov 2026
- Pls find enclosed Earnings Call Written Transcript · 04 Nov 2026
- Pls find enclosed Audio recording of Earnings Call · 30 Oct 2026
- Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
- Pls find enclosed results for the quarter ended 30.09.2026. · 30 Oct 2026
- Pls find enclosed Financial Results for the quarter ended 30.09.2026. · 30 Oct 2026
